Medytox Obtains Product Approval for Botox and Fillers in Saudi Arabia and Three Other Countries
[Asia Economy Reporter Cho Hyun-ui] Medytox announced on the 7th that its botulinum toxin product 'Medytoxine' and hyaluronic acid filler 'Neuramis' have obtained marketing approval in a total of four countries.
Medytox stated that Medytoxine recently received marketing approval in Malaysia and Saudi Arabia. The company plans to target the Islamic market based on Medytoxine's entry into Saudi Arabia.
Neuramis recently obtained marketing approval in Brazil and the Philippines, expanding its presence to 44 countries. The company also plans to obtain marketing approval in Taiwan, Mexico, and El Salvador within this year.
Hot Picks Today
While Samsung Falters, China Rises: "Chinese DRAM" Turns a Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- Despite Captivating the Nation for Over a Month... "Timmy" the Whale Ultimately Found Dead
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
A Medytox representative said, "We will prioritize expanding our global market presence to achieve continuous sales growth and enhance our corporate brand."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
